685
Views
2
CrossRef citations to date
0
Altmetric
Editorial

How costly is non-adherence to infliximab in patients with Crohn’s disease?

Pages 881-882 | Accepted 08 Sep 2014, Published online: 26 Sep 2014
 

Transparency

Declaration of funding

No funding was received for this manuscript.

Declaration of financial/other relationships

CS has no conflicts of interest of financial disclosures relevant to this manuscript. JME peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.